Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.2K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.2K
Expected Value01:15

Expected Value

7.8K
The expected value is known as the "long-term" average or mean. This means that over the long term of experimenting over and over, you would expect this average. The expected average is represented by the symbol μ. It is calculated as follows:
7.8K
Timing and Consequences on Behavior01:08

Timing and Consequences on Behavior

376
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective. 
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
376
Switching of BJT01:22

Switching of BJT

841
Switching behavior in Bipolar Junction Transistors (BJTs) is a fundamental aspect utilized in various electronic circuits, particularly for digital logic applications like switches and amplifiers. In a typical switching circuit, a BJT alternates between cut-off and saturation modes, corresponding to the "off" and "on" states, respectively, thus behaving like an ideal switch.
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
841
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Determination of Expected Frequency01:08

Determination of Expected Frequency

2.6K
Suppose one wants to test independence between the two variables of a contingency table. The values in the table constitute the observed frequencies of the dataset. But how does one determine the expected frequency of the dataset? One of the important assumptions is that the two variables are independent, which means the variables do not influence each other. For independent variables, the statistical probability of any event involving both variables is calculated by multiplying the individual...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model.

JAMA cardiology·2021
Same author

Does the left circumflex coronary artery location impact on the success of chronic total occlusion recanalization? A single-center cohort study.

Scandinavian cardiovascular journal : SCJ·2020
Same author

Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems.

International journal of cardiology·2020
Same author

When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by Ticagrelor.

Journal of the American Heart Association·2020
Same author

Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials.

European heart journal·2020
Same author

Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry.

Circulation. Cardiovascular interventions·2020
Same journal

Interplay between Na<sup>+</sup>/K<sup>+</sup>-ATPase-dependent Src-mediated Ca<sup>2+</sup> sensitization and BK<sub>Ca</sub> channel negative feedback regulates rat mesenteric artery contraction.

Vascular pharmacology·2026
Same journal

Generation and validation of a Myh11Dre-Spp1Cre intersectional mouse model for lineage tracing of disease-associated smooth muscle cell states.

Vascular pharmacology·2026
Same journal

Prediction of peri-procedural cerebrovascular accidents in patients with severe peripheral artery disease undergoing transcatheter aortic valve replacement.

Vascular pharmacology·2026
Same journal

Vascularized tumor organoids as models for interpreting therapeutic response.

Vascular pharmacology·2026
Same journal

Spermidine ameliorates BK channel dysfunction in diabetic coronary smooth muscle cells via PKM2/STAT3/FBXO32 axis.

Vascular pharmacology·2026
Same journal

Reassessing the role of PPARgamma in vascular effects of cannabinoids: A critical appraisal.

Vascular pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jan 27, 2026

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.6K

Switching between P2Y12 inhibitors: Rationale, methods, and expected consequences.

Piera Capranzano1, Davide Capodanno1

  • 1Cardiology Division, CAST Policlinico Hospital, University of Catania, Catania, Italy.

Vascular Pharmacology
|March 17, 2019
PubMed
Summary
This summary is machine-generated.

Physicians can switch between oral P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and intravenous cangrelor based on patient needs. Switching strategies aim to maintain continuous platelet inhibition and optimize clinical outcomes after procedures.

More Related Videos

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

15.1K
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K

Related Experiment Videos

Last Updated: Jan 27, 2026

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.6K
Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

15.1K
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Oral P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) have distinct pharmacological profiles.
  • Intravenous cangrelor offers rapid onset/offset antiplatelet action, necessitating oral transition post-intervention.

Purpose of the Study:

  • To summarize evidence on switching P2Y12 inhibitor therapies.
  • To address practical aspects of switching: rationale, methods, and clinical impact.

Main Methods:

  • Review of pharmacodynamic studies on P2Y12 inhibitor switching.
  • Analysis of clinical outcome studies related to P2Y12 inhibitor transitions.
  • Synthesis of expert consensus and practice guideline recommendations.

Main Results:

  • Pharmacodynamic data guide safe switching of P2Y12 inhibitors regarding timing and dosage.
  • Studies assess the clinical impact of switching between P2Y12 inhibitors.
  • Evidence supports the development of guidelines for P2Y12 inhibitor switching.

Conclusions:

  • Switching P2Y12 inhibitors is a viable strategy in specific clinical scenarios.
  • Understanding switching protocols is crucial for maintaining effective platelet inhibition.
  • Clinical consequences of switching P2Y12 inhibitors are informed by current evidence and guidelines.